Preferential selection of deletion mutations of the outer membrane lipoprotein gene of Escherichia coli by globomycin.

AUTOR(ES)

Zwiebel, L J

RESUMO

Globomycin is an antibiotic which inhibits the processing of the prolipoprotein. Eighty globomycin-resistant mutants were independently isolated from Escherichia coli K-12 which had a deletion mutation in chromosomal lipoprotein gene (lpp), but contained a plasmid carrying the wild-type lpp gene. Twenty-six of the mutants did not have the lipoprotein in the membrane fractions. From the analysis of the plasmids of these mutants, all of the lipoprotein-deficient mutations were found to be due to deletion mutations around the lpp gene.

Documentos Relacionados

• Existence of the bound form of prolipoprotein in Escherichia coli B cells treated with globomycin.
• Gene dosage effects of the structural gene for a lipoprotein of the Escherichia coli outer membrane.
• Globomycin sensitivity of Escherichia coli and Salmonella typhimurium: effects of mutations affecting structures of murein lipoprotein.
• Inhibition of secretion of a mutant lipoprotein across the cytoplasmic membrane by the wild-type lipoprotein of the Escherichia coli outer membrane.
• Restriction enzyme cleavage sites surrounding the structural gene for the lipoprotein of the Escherichia coli outer membrane.